In the longer-term context, GSK's total shareholder return, including dividends and share price movement, experienced a marginal 0.05% decline over the past five years. This performance indicates ...

GSK PLC closed 26.98% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

GSK PLC closed 30.68% below its 52-week high of £18.24, which the company achieved on May 16th.

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

NEW YORK CITY, NY / ACCESS Newswire / April 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Trump said overnight that the US would soon introduce a 'major tariff' on pharmaceuticals to force firms to relocate medicine production to America.

In a jobs market marred by a hiring slowdown, Staffline (STAF) appears to be bucking the trend. Unlike its larger peers, the Aim-listed blue-collar recruiter grew revenue, underlying operating profits ...

Haleon is not issuing any new shares as a result of the flotation, with existing GSK shareholders getting one share in the new company for each they own. GSK shareholders hold around 54.5% of ...